Catalyst Wire Dossier Catalyst Wire Dossier

MMRV vaccine V221-016

· Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MMRV vaccine V221-016, covering 2019-11-15 to 2019-11-15. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016) [Phase 3]

See pricing